The authors reviewed data pertaining to infections associated with DD and SCS. Sources of
data included published1 and unpublished clinical study data, postmarket and medical …

Direct neuroaxis drug delivery has expanded the physician's armamentarium to provide
treatment options to those who have failed more conservative interventions. Starting from …

Object This single-center study investigated adverse events that occurred in children and
adolescent patients treated with intrathecal baclofen (ITB) therapy for spasticity and/or …

In March 2004, a multidisciplinary conference,“ITB Therapy Best Practice Forum,” was held
in Minneapolis, Minnesota. The goal of the conference was to develop recommendations for …

Object Intrathecal baclofen therapy is an effective means of treating intractable spasticity and
dystonia in the pediatric and adult population. The authors present a review of complications …

Background The aim of this study was to investigate and evaluate complications of
intrathecal baclofen (ITB) pump implantation and maintenance in children with cerebral …

Object The authors investigated the efficacy of intrathecal baclofen therapy, analyzing the
complications and risk factors in 200 consecutive patients who received pump implants …

Object The purpose of this study was to determine the frequency of infection and to identify
risk factors for infection in connection with the implantation of an intrathecal baclofen (ITB) …

Purpose Intrathecal baclofen (ITB) therapy is an accepted treatment modality for spasticity
and dystonia. Several complications related to ITB have been described, including …

Aim: To describe complications and outcomes of intrathecal baclofen (ITB) therapy in
children with spasticity and/or dystonia. Methods: A prospective study of goal attainment …